- Home
- SA vs ARDX Comparison
SA vs ARDX Comparison
Compare SA & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SA
- ARDX
- Stock Information
- Founded
- SA 1979
- ARDX 2007
- Country
- SA Canada
- ARDX United States
- Employees
- SA N/A
- ARDX N/A
- Industry
- SA Precious Metals
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- SA Basic Materials
- ARDX Health Care
- Exchange
- SA Nasdaq
- ARDX Nasdaq
- Market Cap
- SA 1.1B
- ARDX 1.4B
- IPO Year
- SA N/A
- ARDX 2014
- Fundamental
- Price
- SA $11.29
- ARDX $5.06
- Analyst Decision
- SA
- ARDX Buy
- Analyst Count
- SA 0
- ARDX 8
- Target Price
- SA N/A
- ARDX $9.93
- AVG Volume (30 Days)
- SA 808.0K
- ARDX 3.6M
- Earning Date
- SA 03-28-2025
- ARDX 02-20-2025
- Dividend Yield
- SA N/A
- ARDX N/A
- EPS Growth
- SA N/A
- ARDX N/A
- EPS
- SA N/A
- ARDX N/A
- Revenue
- SA N/A
- ARDX $333,615,000.00
- Revenue This Year
- SA N/A
- ARDX $169.30
- Revenue Next Year
- SA N/A
- ARDX $14.87
- P/E Ratio
- SA N/A
- ARDX N/A
- Revenue Growth
- SA N/A
- ARDX 168.06
- 52 Week Low
- SA $10.87
- ARDX $4.32
- 52 Week High
- SA $20.55
- ARDX $9.83
- Technical
- Relative Strength Index (RSI)
- SA 40.23
- ARDX 41.70
- Support Level
- SA $11.21
- ARDX $5.37
- Resistance Level
- SA $12.23
- ARDX $6.55
- Average True Range (ATR)
- SA 0.53
- ARDX 0.31
- MACD
- SA -0.12
- ARDX -0.02
- Stochastic Oscillator
- SA 3.43
- ARDX 0.67
About SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.